22-10-2026 06:38 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Historical Volume
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 407.63
NSE Code AUROPHARMA
Dividend Yield % 0.25
Market Cap 906939.41
P/E 34.98
EPS 45.06
Face Value 1  
Exchange : Period From : To :
DateOpen PriceHigh PriceLow PriceClose PriceVolumeTurnover
21-Oct-2026 1621.40 1635.35 1564.10 1576.25 132802 208631227
19-Oct-2026 1660.35 1679.95 1615.00 1615.00 7388 12196967
16-Oct-2026 1683.55 1683.55 1654.75 1660.00 11193 18640311
15-Oct-2026 1645.00 1684.80 1645.00 1675.00 168004 281410912
14-Oct-2026 1683.00 1686.00 1654.70 1661.35 8907 14883947
13-Oct-2026 1708.50 1708.50 1665.10 1683.00 47022 78727991
12-Oct-2026 1697.00 1714.90 1680.55 1702.75 30502 51891040
09-Oct-2026 1642.05 1697.30 1633.35 1686.10 13288 22150954
08-Oct-2026 1670.00 1679.90 1642.00 1642.00 11995 19891015
07-Oct-2026 1697.70 1697.85 1670.20 1685.00 9582 16156377
06-Oct-2026 1677.65 1694.30 1672.80 1690.00 6344 10682351
05-Oct-2026 1739.95 1739.95 1664.15 1670.00 68083 114005218
01-Oct-2026 1675.20 1700.40 1655.80 1675.00 22081 37036318
Page 1 of 1
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.